Article
Dual therapy with corticosteroid ablates the beneficial effect of DP2 antagonism in chronic experimental asthma
2023-11-15
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Prostaglandin D2 (PGD2) signals via the DP1 and DP2 receptors. In Phase II trials, DP2 antagonism decreased airway inflammation and airway smooth muscle (ASM) area in patients with moderate-to-severe asthma, but in the Phase III clinical trials, DP2 antagonism failed to significantly lower the rate of exacerbations. Here, we hypothesised that DP2 antagonism resolves establis...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3def7d58-5ad0-50e1-8a93-838afd9578ba
- DOI
- 10.1101/2023.11.12.566772
